TOP25 728X90
SEARCH RESULTS FOR: "mdt"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2023(1)
2022(8)
2021(6)
2020(12)
2019(4)
2018(8)
2017(8)
2016(9)
2015(8)
2014(2)
CATEGORIES
5-Minute Market Rundown(2)
Analyst Update(5)
Analyst Upgrades(1)
Bernie's Content(1)
Buzz Stocks(20)
Ezines(1)
General(1)
Indexes and ETFs(1)
Intraday Option Activity(2)
Midday Market Check(2)
Monday Morning Outlook(1)
Opening View(16)
Options Recommendations(1)
Stocks On the Move(3)
The Week Ahead(11)
Trader Content(1)

3/29/2023 11:11 AM
UBS hit Medtronic PLC (NYSE:MDT) with a downgrade to "sell" from "buy," with a steep price-target cut to $79 from $127. The firm stated that "despite the company's ongoing transformation, the firm lacks conviction that it can return to sustainable, mid-single digit top-line growth" and added that is has been losing share in some of its highest growth businesses such as diabetes. At last glance, MDT was down 0.7% at $78.79. Long-term pressure at the descending 200-day moving average helped
11/22/2022 7:25 AM
. Jack In The Box will report its Q4 earnings of 2022 before the bell today. Medtronic plc (NYSE:MDT
11/8/2022 9:05 AM
lowers bookings outlook; Foxconn increases stake in Lordstown Motors; and MDT plummets on study data, -to-date deficit. The shares of medical technology company Medtronic PLC (NYSE:MDT) are 5.3% lower
8/29/2022 1:23 AM
Since pushing to an all-time high in September 2021, Medtronic ( NYSE: MDT ) has been falling, in its fiscal year 2023 first quarter. MDT stock feel 4% on the news. Later in the week the stock, . However, the volatile price action with MDT stock shows why context matters in investing. The company’s, by MarketBeat gives MDT stock a Hold with a price target of $112.10. With that in mind, I’ll admit that investors should maintain a realistic outlook for MDT stock in the short term
8/24/2022 10:14 AM
Raymond James is losing confidence in the growth potential for Medtronic PLC (NYSE:MDT), according to a bear note the firm issued earlier today. The analyst downgraded MDT to "market perform" from, dynamics have disrupted MDT's growth more so than peers, and our concern is that it will take longer for MDT to regain momentum." While Raymond James withheld a price target, Piper Sandler and Evercore ISI, expectations. What's more, MDT's Schaeffer's Volatility Scorecard (SVS) tally of 74 out of 100 implies